Stocks and InvestingStocks and Investing
Mon, February 14, 2022
Fri, February 11, 2022
Thu, February 10, 2022
Wed, February 9, 2022
Tue, February 8, 2022

David Turkaly Maintained (ZBH) at Buy with Decreased Target to $145 on, Feb 8th, 2022


Published on 2024-10-27 19:36:59 - WOPRAI, David Turkaly
  Print publication without navigation


David Turkaly of JMP Securities, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Decreased Target from $175 to $145 on, Feb 8th, 2022.

David has made no other calls on ZBH in the last 4 months.



There are 9 other peers that have a rating on ZBH. Out of the 9 peers that are also analyzing ZBH, 6 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew O'Brien of "Piper Sandler" Maintained at Hold with Decreased Target to $110 on, Monday, February 7th, 2022
  • Matthew Taylor of "UBS" Downgraded from Strong Buy to Hold and Decreased Target to $130 on, Wednesday, February 2nd, 2022
  • Ryan Zimmerman of "BTIG" Downgraded from Strong Buy to Hold on, Monday, January 10th, 2022
  • Cecilia Furlong of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $145 on, Friday, January 7th, 2022
  • Matt O'Brien of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $135 on, Tuesday, January 4th, 2022
  • David Toung of "Argus Research" Downgraded from Strong Buy to Hold on, Tuesday, November 23rd, 2021


These are the ratings of the 3 analyists that currently disagree with David


  • Larry Biegelsen of "Wells Fargo" Downgraded from Buy to Sell and Decreased Target to $124 on, Wednesday, January 19th, 2022
  • Jason Wittes of "Loop Capital" Initiated at Strong Buy and Held Target at $165 on, Tuesday, December 7th, 2021
  • Anthony Petrone of "Jefferies" Maintained at Strong Buy with Decreased Target to $175 on, Friday, November 5th, 2021